Baldwin Investment Management LLC Acquires 74 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Baldwin Investment Management LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,800 shares of the healthcare conglomerate’s stock after purchasing an additional 74 shares during the period. Baldwin Investment Management LLC’s holdings in UnitedHealth Group were worth $1,637,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. China Universal Asset Management Co. Ltd. increased its position in shares of UnitedHealth Group by 20.6% during the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after buying an additional 1,857 shares during the period. Quent Capital LLC lifted its stake in shares of UnitedHealth Group by 5.5% in the 1st quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after purchasing an additional 217 shares during the period. Coppell Advisory Solutions Corp. acquired a new stake in UnitedHealth Group during the first quarter worth approximately $752,000. Advisory Resource Group bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at $209,000. Finally, Vima LLC increased its stake in UnitedHealth Group by 40.3% in the first quarter. Vima LLC now owns 411 shares of the healthcare conglomerate’s stock valued at $194,000 after purchasing an additional 118 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.1 %

Shares of NYSE:UNH opened at $606.32 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market capitalization of $557.98 billion, a price-to-earnings ratio of 39.50, a PEG ratio of 1.78 and a beta of 0.58. The stock’s 50-day simple moving average is $583.53 and its two-hundred day simple moving average is $554.65. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 EPS. Analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.39%. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.